DK0700930T3 - Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet - Google Patents

Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet

Info

Publication number: DK0700930T3
Authority: DK; Denmark
Prior art keywords: amino acid; peptide; radioactive; acid sequence; acid residues
Prior art date: 1994-06-07

Application number

DK95108681T

Other languages

Danish (da)

English (en)

Inventor

Ikuya Seki

Yoshitoshi Itaya

Yoshifumi Shirakami

Komei Washino

Original Assignee

Nihon Mediphysics Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-06-07

Filing date

1995-06-06

Publication date

1999-09-13

1995-06-06 Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd

1999-09-13 Application granted granted Critical

1999-09-13 Publication of DK0700930T3 publication Critical patent/DK0700930T3/da

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1018—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against material from animals or humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
- A61K51/10—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody
- A61K51/1045—Antibodies or immunoglobulins; Fragments thereof, the carrier being an antibody, an immunoglobulin or a fragment thereof, e.g. a camelised human single domain antibody or the Fc fragment of an antibody against animal or human tumor cells or tumor cell determinants
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Veterinary Medicine (AREA)
Physics & Mathematics (AREA)
Optics & Photonics (AREA)
Molecular Biology (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Cell Biology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

DK95108681T 1994-06-07 1995-06-06 Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet DK0700930T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP14865594		1994-06-07

Publications (1)

Publication Number	Publication Date
DK0700930T3 true DK0700930T3 (da)	1999-09-13

Family

ID=15457667

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95108681T DK0700930T3 (da)	1994-06-07	1995-06-06	Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet

Country Status (11)

Country	Link
US (1)	US5827498A (fr)
EP (1)	EP0700930B1 (fr)
KR (1)	KR960000250A (fr)
AT (1)	ATE175977T1 (fr)
AU (1)	AU684348B2 (fr)
CA (1)	CA2151099A1 (fr)
DE (1)	DE69507408T2 (fr)
DK (1)	DK0700930T3 (fr)
ES (1)	ES2138111T3 (fr)
MC (1)	MC2397A1 (fr)
TW (1)	TW394777B (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2165228A1 (fr) *	1994-12-27	1996-06-28	Yoshitoshi Itaya	Peptides formant des chelates metalliques et leur utilisation
JP6087289B2 (ja) *	2010-12-14	2017-03-01	レセプタバイオファーマエス．エー．	Ｎａｐｉ２ｂ輸送体に対するヒト化モノクローナル抗体の相補性決定領域に由来する抗腫瘍ペプチド
EP3434276B1 (fr)	2012-06-06	2024-10-30	Pepkon	Procédé et composition pharmaceutique à utiliser dans le traitement du cancer
AU2018321825A1 (en) *	2017-08-19	2020-03-05	Ohio State Innovation Foundation	Novel peptide-based cancer imaging agents
CN107550864B (zh) *	2017-08-23	2020-12-18	科笛生物医药(上海)有限公司	Eppt多肽-聚乙二醇-磷脂复合膜材料、其制备方法及主动靶向脂质体递药系统和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5322678A (en) *	1988-02-17	1994-06-21	Neorx Corporation	Alteration of pharmacokinetics of proteins by charge modification
EP0442926A1 (fr) *	1988-11-10	1991-08-28	Imperial Cancer Research Technology Limited	Polypeptides
US4986979A (en) *	1989-03-14	1991-01-22	Neorx Corporation	Imaging tissue sites of inflammation
DE69230525T2 (de) *	1991-02-08	2000-06-21	Diatide, Inc.	Technetium-99m markierte Polypeptide zur Bildformung
GB9108652D0 (en) *	1991-04-23	1991-06-12	Antisoma Ltd	Immunoreactive compounds

1995
- 1995-06-05 US US08/463,230 patent/US5827498A/en not_active Expired - Fee Related
- 1995-06-05 AU AU20499/95A patent/AU684348B2/en not_active Ceased
- 1995-06-06 CA CA002151099A patent/CA2151099A1/fr not_active Abandoned
- 1995-06-06 DE DE69507408T patent/DE69507408T2/de not_active Expired - Fee Related
- 1995-06-06 DK DK95108681T patent/DK0700930T3/da active
- 1995-06-06 EP EP95108681A patent/EP0700930B1/fr not_active Expired - Lifetime
- 1995-06-06 ES ES95108681T patent/ES2138111T3/es not_active Expired - Lifetime
- 1995-06-06 AT AT9595108681T patent/ATE175977T1/de active
- 1995-06-07 KR KR1019950014923A patent/KR960000250A/ko not_active Withdrawn
- 1995-11-16 TW TW084112123A patent/TW394777B/zh active
- 1995-11-28 MC MC2323A patent/MC2397A1/fr unknown

Also Published As

Publication number	Publication date
ES2138111T3 (es)	2000-01-01
US5827498A (en)	1998-10-27
TW394777B (en)	2000-06-21
EP0700930A1 (fr)	1996-03-13
AU2049995A (en)	1995-12-14
AU684348B2 (en)	1997-12-11
DE69507408D1 (de)	1999-03-04
KR960000250A (ko)	1996-01-25
EP0700930B1 (fr)	1999-11-03
CA2151099A1 (fr)	1995-12-08
MC2397A1 (fr)	1996-07-26
ATE175977T1 (de)	1999-02-15
DE69507408T2 (de)	2000-05-18

Similar Documents

Publication	Publication Date	Title
MX9709913A (es)	1998-08-30	Metaloconstrucciones determinadas estructuralmente y aplicaciones.
MX9707430A (es)	1997-12-31	Complejos radiofarmaceuticos ternarios.
ATE146477T1 (de)	1997-01-15	Antimitotische derivate von binären catharanthus roseus
DE69230755D1 (de)	2000-04-13	Porphycenverbindungen zur photodynamischen therapie
AU579387B2 (en)	1988-11-24	New tetrapyrrole therapeutic agents
DK197386D0 (da)	1986-04-30	Terapeutiske praeparater til brug ved fotodiagnose og fototerapi
ES2146256T3 (es)	2000-08-01	Agentes de contraste que contienen perfluoro-1h,1h-neopentilo y metodo para usar el mismo.
GB9308957D0 (en)	1993-06-16	Novel produgs
DE69419919D1 (de)	1999-09-09	Technetium-99m markierte peptide zur bilderzeugung der entzuendung
FR2707300B1 (fr)	1995-09-22	Composition de savon solide, transparente, à base de sels d'acides gras contenant de l'isoprèneglycol.
RU2002123877A (ru)	2004-01-10	Кахалалидные соединения
DK0700930T3 (da)	1999-09-13	Tumoraffinitetspeptid og radioaktivt diagnosticeringsmiddel og radioaktivt behandlingsmiddel indeholdende peptidet
BR9207126A (pt)	1995-08-29	Imunorreagente radioativo de marcação,composição formadora de imagem,composição terapêutica,processo para a formação de imagem diagnóstica em um sítio em um paciente e para tratar sítios de doença em um paciente,e,composição de matéria
ZA919075B (en)	1992-08-26	Complexes containing s(+)-phenyl alkane acids and amino sugars
ES2096040T3 (es)	1997-03-01	Nuevo reactivo para la representacion grafica de los tumores y su terapia.
GR1002903B (el)	1998-05-12	Πεπτιδιο συγγενες με ογκο και ραδιενεργος διαγνωστικος παραγοντας και ραδιενεργος θεραπευτικος παραγοντας που περιεχει το πεπτιδιο.
DK638088D0 (da)	1988-11-15	Substituerede dicarboxylsyre-bis(3,5-dicarbamoyl-2,4,6-trijodanilider), fremgangsmaade til fremstilling deraf samt roentgenkontrastmidler indeholdende disse
EP0659764B1 (fr)	2000-03-01	Peptides modifiées par un groupe phosphine pour le marquage avec 99mTC et 186-188 Re ou avec des agents paramagnétiques
BR9407347A (pt)	1996-10-08	Complexos de sulfato de tris (isonitrila) cobre I método para sua preparação método para a preparação de um complexo de coordenação de uma isonitrila ligante e radionuclídeo kit estéril e não pitogênico para a sua preparação
GR3005520T3 (fr)	1993-06-07
KR940014436A (ko)	1994-07-18	2-아미노-6,7-디히드록시-4-티아헵탄산 유도체, 그의 제조방법 및 용도
DE3063755D1 (en)	1983-07-21	Technetium-99m labeled acetanilidoiminodiacetates for liver function diagnosis and process for their preparation
US5734011A (en)	1998-03-31	Ligand precursors for incorporation into peptides
ES2043784T3 (es)	1994-01-01	Procedimiento de preparacion de compuestos guanidinicos.
ATE89567T1 (de)	1993-06-15	Konjugate von vinblastin und seine derivate, verfahren zur herstellung derselben und diese konjugate enthaltende pharmazeutische zusammensetzungen.